Delivery Order #15B40827F00000032

McKesson Delivery Order for Controlled Pharmaceuticals under VA Prime Vendor Contract

This award represents a delivery order contract issued under the substantial Pharmaceutical Prime Vendor Contract (PPV), an indefinite delivery vehicle held by McKesson Corporation. McKesson, a prominent pharmaceutical distributor, is tasked with supplying controlled pharmaceutical products specifically for the Department of Veterans Affairs (VA). The contract supports a critical ongoing program to provide essential medications to veterans, thereby enhancing healthcare delivery within the public sector. The current delivery order covers the management and delivery of controlled substances scheduled for the month of October 2026, in accordance with the terms of the overarching PPV contract. The scope involves coordinating pharmaceutical distribution from McKesson's facility in Irving, Texas. This delivery order builds on the significant multi-year PPV contract known for stabilizing medication access for veterans nationwide. It was competitively awarded under the existing contract framework, enabling efficient procurement without additional bidding. The performance period for this order is one month, marking an important scheduled milestone within the long-term contract. The parent PPV contract, with a total potential value in the multi-billion-dollar range, was awarded to McKesson following full and open competition and has been ongoing since 2020 to 2028.

Description

MCKESSON CONTROLLED PHARMACEUTICALS FY27 OCTOBER 2026 IAW T&C: 36W79720D0001

View original record